The first randomized, placebo-controlled clinical trial evaluating the impact of therapeutic monoclonal antibodies on the risk of developing long COVID was led by researchers at Weill Cornell Medicine.
AI-powered tool enhances handheld ultrasound for heart imaging
A handheld, portable ultrasound probe that’s the size of a fat window squeegee can peer inside your heart – but this amazing piece of technology